No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SLNO Soleno Therapeutics
- 46.9600
- +0.5700+1.23%
Close Jul 19 16:00 ET
1.73BMarket Cap-22685P/E (TTM)
48.2900High46.0400Low193.89KVolume46.5000Open46.3900Pre Close9.16MTurnover1.10%Turnover RatioLossP/E (Static)36.86MShares53.820052wk High12.07P/B830.59MFloat Cap3.690052wk Low--Dividend TTM17.69MShs Float742.5000Historical High--Div YieldTTM4.85%Amplitude0.8500Historical Low47.2520Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Have Insiders Sold Soleno Therapeutics Shares Recently?
We wouldn't blame Soleno Therapeutics, Inc. (NASDAQ:SLNO) shareholders if they were a little worried about the fact that Anish Bhatnagar, the President recently netted about US$800k selling shares at
Form 144 | Soleno Therapeutics(SLNO.US) Director Proposes to Sell 506.64K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Soleno Therapeutics(SLNO.US)$ Director Melincoff Gwen A intends to sell 12,666 shares of its common stock on Jun 28, with a total market value of approximately $506.64
Express News | Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for Dccr (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
Express News | Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Express News | Soleno Therapeutics Inc - Set to Join Russell 3000 Index
Soleno Therapeutics Set to Join Russell 3000 Index
REDWOOD CITY, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases,
Comments
» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
8
Despite the increase in cash burn, the company's solid cash runway and the analysts' forecast of reaching breakeven point suggest a positive outlook. The company's cash burn relative to its market capitalisation, which is US$1.4b, is about 1.7%, indicating that it could potentially raise more cash easily if needed.
From small cap to big cap, it is interesting.
Now they have a way to treat diabetes, obesity. I believe later they will find a way to cure cancer, Alzheimer and other disease not just treat it and prevent it.
To clone something is unreal before, even travel to mars is real now. ( $Virgin Galactic(SPCE.US$
thank you for wonderful run $Tempest Therapeutics(TPST.US$ $Soleno Therapeutics(SLNO.US$ $Arcutis Biotherapeutics(ARQT.US$ $2seventy bio(TSVT.US$ $Redhill Biopharma(RDHL.US$ etc... th...
Now they have a way to treat diabetes, obesity. I believe later they will find a way to cure cancer, Alzheimer and other disease not just treat it and prevent it.
To clone something is unreal before, even travel to mars is real now. ( $Virgin Galactic(SPCE.US$
thank you for wonderful run $Tempest Therapeutics(TPST.US$ $Soleno Therapeutics(SLNO.US$ $Arcutis Biotherapeutics(ARQT.US$ $2seventy bio(TSVT.US$ $Redhill Biopharma(RDHL.US$ etc... th...
4
Is it Nvidia, the maker of chips related to artificial intelligence? This is despite the fact that the stock has soared more than 200% this year. Other big tech stocks like Apple are up nearly 50% this year, Microsoft is up about 56%, Google parent Alphabet's Class A and Class C shares are up nearly 60% each, Amazon is up more than 80%, Tesla has doubled more than doubled, and Meta almost tripled.
However, none of these stoc...
However, none of these stoc...
4
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg